New Minimally-Invasive Procedure Available for Patients with
Dangerous Condition in the Legs Linked to Heart Health
Charmaine Weis, Director of Marketing
(303) 498-1482 or firstname.lastname@example.org
Platte Valley Medical Center today announced it is the first hospital in Colorado and one of the first in the nation to offer a new minimally-invasive procedure to treat peripheral artery disease (PAD) in the upper leg. PAD is a serious and common condition associated with a four- to five-fold increased risk for heart attack and stroke
The procedure was performed on February 3 by Interventional Cardiologist Qaisar Khan, M.D. in PVMC’s Heart Cath Lab. Dr. Khan used a drug-coated balloon recently approved by the Food and Drug Administration (FDA) to treat advanced PAD in the upper left leg of his patient Robert Canterbury.
Plagued by severe blockages in the arteries of both legs, Robert received multiple stents to restore blood flow to his legs in the past two years. Unfortunately, scar tissue built up within the stents and blocked the arteries each time. With few other interventional options available, Robert was hopeful to become one of the first to receive the new procedure.
“My doctor tried to repair the arteries in my left leg, but couldn’t because there was so much scar tissue buildup. Then I was referred to Dr. Khan at Platte Valley Medical Center,” explains Robert. “I am so happy I met Dr. Khan. He is great; he knows what he’s doing and has that special personal touch. And when he told me about the new drug-coated balloons, I was ecstatic.”
Less than 24 hours after surgery, Robert was up and briskly walking.
Prior to the procedure, Mr. Canterbury’s arteries in his left leg were 100% blocked. “The nurse couldn’t find a pulse on my left foot using a Doppler,” he said. “After the procedure, the blood was fully restored. My nurse could feel the pulse with his bare hands through my socks!”
Although it affects an estimated eight to 12 million people in the U.S., only 25% of adults are aware of the disease and how dangerous it can be. PAD is a debilitating disease that occurs when arteries become narrowed or blocked by plaque build-up, restricting blood flow. PAD commonly affects arteries in the upper legs and can cause recurrent and painful muscle cramping in the thigh and/or upper calf. The pain can be described as dull, causing heaviness or tightness in the muscles, but often will stop when the person is at rest. Experiencing pain, even while at rest or while sleeping, is a sign of a more severe disease. If not properly treated, PAD can lead to life-threatening complications.
Drug-coated balloons are designed to help restore blood flow by reopening blocked arteries and delivering a medication to the artery wall that clinical studies have shown helps keep the artery open longer than other available therapies. During the procedure, an inflated balloon pushes the plaque away to create a channel for blood flow and the medication on the balloon surface in absorbed into the artery wall. The balloon is then removed with only the medication left behind.
“What many people don’t realize is that PAD in the legs is often connected to health conditions in other parts of the body, especially in the heart,” said Simona Zannetti, MD, vice president of clinical and medical affairs of Medtronic’s Aortic and Peripheral Vascular business. “With drug-coated balloons, we now have a way to more effectively treat PAD, and we are excited that hospitals in the U.S. are now able to offer this new therapy.”
“At Platte Valley Medical Center, we embrace and adapt to the latest technology very quickly,” says Dr. Khan. “We were the first in the state of Colorado to implant a cardiac rhythm monitor, and now are the first in the state to use the drug-eluting balloon to help patients in our community.”
PVMC has chosen to use the IN.PACT Admiral drug-coated balloon by Medtronic because it has demonstrated the best results observed to date in the treatment of PAD in the upper legs. In particular, studies have shown treatment with the IN.PACT Admiral drug-coated balloon reduces the need to have a similar repeat procedure within the next year, which is more common with other types of interventional procedures for the treatment of the condition.
“While technology plays an important role in treating advanced cardiovascular conditions, I believe our exceptional clinical team from our Cath Lab and Intensive Care Unit is equally significant,” explains PVMC’s Chief Operating Officer Kurt Gensert. “They are highly skilled to treat and care for some of the most progressive illnesses our patients face.”